https://www.nature.com/articles/s41375-022-01713-y
0
0
10/14/22 at 7:52pm
Organization
Nature.com
54 words
0
Comments
Leukemia - Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification: a post-hoc analysis of the PETAL trial
You are the first to view
Create an account
or login to join the discussion